EcoDrugPlus

Integrin Subunit Beta 3

Ensembl ID : ENSMPUG00000008075
Gene Symbol: ITGB3
1 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSMPUG00000004287
Gene Symbol: ITGB5
2 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSMPUG00000000535
Gene Symbol: ITGB6
2 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSMPUG00000006121
Gene Symbol: ITGB7
4 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSMPUG00000013932
Gene Symbol: ITGB8
2 Cross references
202 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSMPUG00000006820
Gene Symbol: ICAM1
2 Cross references
93 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSMPUG00000000361
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSMPUG00000013592
Gene Symbol: IL6
2 Cross references
162 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSMPUG00000000516
Gene Symbol: IDH1
2 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSMPUG00000015739
Gene Symbol: IDH2
2 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSMPUG00000010297
Gene Symbol: KLKB1
2 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSMPUG00000006665
Gene Symbol: KEAP1
2 Cross references
189 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).